Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Marksans Pharma Limited
Press Release May 30 2025
Business
May 30 2025
4 min read

Press Release May 30 2025

Marksans Pharma Limited has informed the Exchange regarding a press release dated May 30, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for the product Metformin Hydrochloride 500 mg/ 5ml Oral Solution.".

View Attachment